Corline Biomedical AB
Develops heparin-based solutions for medical devices and regenerative medicine.
CLBIO | ST
Overview
Corporate Details
- ISIN(s):
- SE0006887451
- LEI:
- 549300KYLOA3DVEPZ069
- Country:
- Sweden
- Address:
- Lefflersgatan 5, 754 50 Uppsala
- Website:
- https://corline.com/
- Sector:
- Manufacturing
Description
Corline Biomedical AB develops, manufactures, and markets heparin-based solutions that provide antithrombotic and anti-inflammatory properties. The company's core technology is the Corline Heparin Surface (CHS™), a proprietary surface coating for the medical device industry designed to improve biocompatibility and manage immune thrombosis. Corline also develops products for the regenerative medicine field, including Renaparin® and Cytoparin™, which are aimed at enhancing outcomes in applications such as kidney transplantation and cell therapies. The company's solutions target significant unmet clinical needs by reducing thrombotic and inflammatory complications when foreign materials or cells are introduced to the body.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Corline Biomedical AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Corline Biomedical AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Corline Biomedical AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
